Huiping Shuai

机构：Chinese University of Hong Kong, University of Hong Kong · ORCID：0000-0001-8078-4113

发表论文 62 篇 · 总被引 5088 次 · h-index 30

代表论文

• An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron (2022 · Nature Microbiology · 被引 103)
• Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2 (2022 · Emerging Microbes & Infections · 被引 88)
• Coronaviruses exploit a host cysteine-aspartic protease for replication (2022 · Nature · 被引 87)
• A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants (2023 · Signal Transduction and Targeted Therapy · 被引 85)
• Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice (2022 · JCI Insight · 被引 70)
• The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5 (2023 · EBioMedicine · 被引 58)